Sequence variation database for the Wilson disease copper transporter, ATP7B

Human Mutation

Volumn 28, Issue 12, 2007, Pages 1171-1177

  Kenney, Susan M ^a   Cox, Diane W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ATP7B; Mutation database; Wilson disease; WND

Indexed keywords

ADENOSINE TRIPHOSPHATASE; WILSON DISEASE PROTEIN;

DATA BASE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; CATION TRANSPORT PROTEINS; DATABASES, GENETIC; HEPATOLENTICULAR DEGENERATION; HUMANS; VARIATION (GENETICS);

EID: 37049036616     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20586     Document Type: Review

References (50)

1. Ala A, Borjigin J, Rochwarger A, Schilsky M. 2005. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41: 668-670.
2. Attri S, Sharma N, Jahagirdar S, Thapa BR, Prasad R. 2006. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Pediatr Res 59(Pt 1):593-597.
3. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. 1993. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327-337.
4. Caca K, Ferenci R Kuhn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mossner J, Berr F. 2001. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 35:575-581.
5. Cater MA, La Fontaine S, Shield K, Deal Y, Mercer JF. 2006. ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion. Gastroenterology 130:493-506.
6. Cox DW, Prat L, Walshe JM, Heathcote J, Gaffney D. 2005. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry. Hum Mutat 26:280.
7. Cox DW, Roberts EA. 2006a. Wilson disease. In: Scharschmidt B, Sleisinger MH, editors. Sleisinger and Fordtran's gastrointestinal disease: pathophysiology, diagnosis, management. Philadelphia: W.B. Saunders. p 1269-1277.
8. Cox DW, Roberts EA. 2006b. Wilson disease. GeneReviews at GeneTests: Medical Genetics Information Resource. Seattle: University of Washington.
9. Cullen LM, Prat L, Cox DW. 2003. Genetic variation in the promoter and 5′ UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet 64:429-432.
10. Curtis D, Durkie M, Balac MR Sheard D, Goodeve A, Peake I, Quarrell O, Tanner S. 1999. A study of Wilson disease mutations in Britain. Hum Mutat 14:304-311.
11. Deguti MM, Genschel J, Cancado EL, Barbosa ER, Bochow B, Mucenic M, Porta G, Lochs H, Carrilho FJ, Schmidt HH. 2004. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 23:398.
12. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extension and suggestion to describe complex mutations: a discussion. Hum Mutat 15:7-12.
13. Figus A, Angius A, Loudianos G, Bertini C, Dessi V, Loi A, Deiana A. 1996. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 57:1318-1324.
14. Firneisz G, Lakatos PL, Szalay F, Polli C, Giant TT, Ferenci R 2002. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 108:23-28.
15. Forbes JR, Cox DW. 1998. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? Am J Hum Genet 63:1663-1674.
16. Forbes JR, Cox DW. 2000. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum Mol Genet 9:1927-1935.
17. Forbes JR, Hsi G, Cox DW. 1999. Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease. J Biol Chem 274:12408-12413.
18. Gu YH, Kodama H, Du SL, Gu QJ, Sun HJ, Ushijima H. 2003. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet 64:479-484.
19. Ha-Hao D, Hefter H, Stremmel W, Castaneda-Guillot C, Hernandez AH, Cox DW, Auburger G. 1998. His 1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet 6:616-623.
20. Hamza I, Schaefer M, Klomp LW, Gitlin JD. 1999. Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc Natl Acad Sci USA 96:13363-13368.
21. Hsi G, Cullen LM, Moira Glerum D, Cox DW. 2004. Functional assessment of the carboxy-terminus of the Wilson disease copper-transporting ATPase, ATP7B. Genomics 83:473-481.
22. Huster D, Hoppert M, Lutsenko S, Zinke J, Lehmann C, Mossner J, Berr F, Caca K. 2003. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology 124:335-345.
23. Iida M, Terada K, Sambongi Y, Wakabayashi T, Miura N, Koyama K, Futai M, Sugiyama T. 1998. Analysis of functional domains of Wilson disease protein (ATP7B) in Saccharomyces cerevisiae. FEBS Lett 428:281-285.
24. Kalinsky H, Funes A, Zeldin A, Pel-Or Y, Korostishevsky M, Gershoni-Baruch R, Farrer LA, Bonne-Tamir B. 1998. Novel ATP7B mutations causing Wilson disease in several Israeli ethnic groups. Hum Mutat 11:145-151.
25. Kim EK, Yoo OJ, Song KY, Yoo HW, Choi SY, Cho SW, Hahn SH. 1998. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat 11:275-278.
26. Liu XQ, Zhang YF, Liu TT, Hsiao KJ, Zhang JM, Gu XF, Bao KR, Yu LH, Wang MX. 2004. Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. World J Gastroenterol 10:590-593.
27. Loudianos G, Dessi V, Lovicu M, Angius A, Kanavakis E, Tzetis M, Kattamis C, Manolaki N, Vassiliki G, Karpathios T, Cao A, Pirastu M. 1998a. Haplotype and mutation analysis in Greek patients with Wilson disease. Eur J Hum Genet 6:487-491.
28. Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti R Akar N, Yagci R, Vegnente A, Cao A, Pirastu M. 1998b. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12:89-94.
29. Loudianos G, Dessi V, Lovicu M, Angius A, Altuntas B, Giacchino R, Marazzi M, Marcellini M, Sartorelli MR, Sturniolo GC, Kocak N, Yuce A, Akar N, Pirastu M, Cao A. 1999a. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet 36:833-836.
30. Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, De Virgiliis S, Nurchi AM, Deplano A, Moi R Pirastu M, Cao A. 1999b. Molecular characterization of Wilson disease in the Sardinian population - evidence of a founder effect. Hum Mutat 14:294-303.
31. Margarit E, Bach V, Gomez D, Bruguera M, Jara R Queralt R, Ballesta F 2005. Mutation analysis of Wilson disease in the Spanish population- identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet 68:61-68.
32. Morgan CT, Tsivkovskii R, Kosinsky YA, Efremov RG, Lutsenko S. 2004. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F. J Biol Chem 279:36363-36371.
33. Nanji MS, Nguyen VT, Kawasoe JH, Inui K, Endo F, Nakajima T, Anezaki T, Cox DW. 1997. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet 60:1423-1429.
34. Okkeri J, Bencomo E, Pietila M, Haltia T 2002. Introducing Wilson discase mutations into the zinc-transporting P-type ATPase of Escherichia coli. The mutation P634L in the 'hinge' motif (GDGXNDXP) perturbs the formation of the E2P state. Eur J Biochem 269:1579-1586.
35. Orru S, Thomas G, Loizedda A, Cox DW, Contu L. 1997. 24bp deletion and Ala1278 to Val mutation of the ATP7B gene in a Sardinian family with Wilson disease. Hum Mutat 10:84-85.
36. Payne AS, Kelly EJ, Gitlin JD. 1998. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci USA 95:10854-10859.
37. Roberts EA, Cox DW. 2006. Wilson disease. In: Boyer T, Manns M, Wright T, editors. Zakim and Boyer's Hepatology. Philadelphia: Elsevier.
38. Roberts EA, Schilsky ML. 2003. A practice guideline on Wilson disease. Hepatology 37:1475-1492.
39. Sallie R, Katsiyiannakis L, Baldwin D. 1992. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 16:1206-1211.
40. Schilsky ML. 2005. Wilson disease: new insights into pathogenesis, diagnosis, and future therapy. Curr Gastroenterol Rep 7:26-31.
41. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K. 1997. Identification and analysis of mutations in the Wilson disease gene (atp7b): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317-328.
42. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, Devoto M, Peppercorn J, Bush AI, Sternlieb I, Pirastu M, Gusella JF, Evgrafov O, Penchaszadeh GK, Honig B, Edelman IS, Soares MB, Scheinberg IH, Gilliam TC. 1993. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344-350.
43. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. 1995. The Wilson disease gene: spectrum of mutations and their consequences. [Erratum in Nat Genet 1995;9:451]. Nat Genet 9:210-217.
44. Tsai CH, Tsai FJ, Wu JY, Chang JG, Lee CC, Lin SP, Yang CF, Jong YJ, Lo MC. 1998. Mutation analysis of Wilson disease in Taiwan and description of six new mutations. Hum Mutat 12:370-376.
45. Waldenstrom E, Lagerkvist A, Dahlman T, Westermark K, Landegren U. 1996. Efficient detection of mutations in Wilson disease by manifold sequencing. Genomics 37:303-309.
46. Walker JM, Tsivkovskii R, Lutsenko S. 2002. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity. J Biol Chem 277:27953-27999.
47. Walker JM, Huster D, Ralle M, Morgan CT, Blackburn NJ, Lutsenko S. 2004. The N-terminal metal-binding site 2 of the Wilson's disease protein plays a key role in the transfer of copper from Atox1. J Biol Chem 279:15376-15384.
48. Wan L, Tsai CH, Tsai Y, Hsu CM, Lee CC, Tsai FJ. 2006. Mutation analysis of Taiwanese Wilson disease patients. Biochem Biophys Res Commun 345:734-738.
49. Wilson DC, Phillips MJ, Cox DW, Roberts EA. 2000. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr 137:719-722.
50. Wu ZY, Zhao GX, Chen WJ, Wang N, Wan B, Lin MT Murong SX, Yu L. 2006. Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med 84:438-442.